A Noida based institute (NCR) has now accepted an offer from Malaysia to provide them with targeted 'dendritic cell' therapy to patients there, after successfully treating hundreds of cancer patients in India. A new treatment that uses cell-based cancer immuno-therapy-treatment using the patient's own mononuclear cells transformed into cancer-specific dendritic (immune system regulatory) cells has been devised by the Institute of Cellular Therapies (ICT).
Through this therapy, medical experts extract the mononuclear (CD14+) cells from the patient's own blood, transform these cells into cancer-fighting cells and implant them back in the patient's body. Denvax helps in correcting the failed immune surveillance and teaches the immune system to recognize and kill cancer cells.
